β-环糊精对氯诺昔康的包合作用

采用荧光光谱、差热扫描和核磁共振法研究了不同酸度和温度下β-环糊精（β-CD）、羟丙基β-环糊精（HP-β-CD）和磺丁醚β-环糊精（SBE-β-CD）对氯诺昔康（LX）的包合特性。 结果表明,3种环糊精与氯诺昔康均形成1∶1的包合物。 以包合常数作为包合稳定性的量度,包合稳定性为SBE-β-CD＞HP-β-CD＞β-CD。     

β-环糊精及其衍生物对脂肪族手性对映体及有机染料的分子识别研究

在25℃用荧光和紫外光谱滴定法分别测定了β-环糊精(β-CD)、2,3,6-三[氧-(2-羟基丙基)]-β-环糊精(HP-β-CD)及2,3,6-三(甲氧基)-β-环糊精(MO-β-CD)与6种脂肪族手性客体和4种染料分子形成超分子配合物的稳定常数.结果表明,多种弱相互作用协同贡献于主-客体的包结配位过程.环糊精衍生物中取代基的疏水性和链长影响主体的配位能力,客体与环糊精间的尺寸适合及疏水相互作用决定其配合物的稳定性.在配位过程中,氢键作用也是影响主体环糊精键合行为的重要因素.     

高效毛细管电泳法手性拆分奥昔布宁对映体

以羟丙基-β-环糊精（HP-β-CD）作为手性选择剂,采用毛细管区带电泳模式,对盐酸奥昔布宁对映体进行手性分离,比较了β-CD和 HP-β-CD之间对药品的分离能力,考察了手性选择剂的浓度、背景电解质的pH 值、柱温、分离电压和三羟甲基氨基甲烷（Tris）在背景电解质磷酸盐中的用量等因素对盐酸奥昔布宁对映体分离的影响,在优化条件下,使盐酸奥昔布宁对映体达到基线分离。结果表明该方法重现性好、简便、快捷、实用性强、具有良好的应用前景。     

阿托伐他汀钙与β-环糊精相互作用的研究及应用

采用线性扫描伏安法和循环伏安法并结合紫外分光光度法研究了新型抗血脂紊乱药物阿托伐他汀钙(AC)与β-环糊精(-βCD)的相互作用.探讨了-βCD对AC的峰电流及AC对-βCD吸附峰电流的影响,测得在0.06mol/LKH2PO4-Na2HPO4(pH=7.17)缓冲溶液中,AC与-βCD包结比为1:1,用电流法测得包结物的形成常数为9.09×104L/mol.根据碱性介质条件下β-CD分子与AC形成包结物而使β-CD吸附峰电流减小的特性,建立了一种利用β-CD间接测定AC的伏安方法.     

醇/盐双水相体系中α-环己基扁桃酸手性分子识别

以含羟丙基-β-环糊精（HP-β-CD）手性识别剂的醇/盐双水相体系作为一种新型的手性识别萃取体系,研究了α-环己基扁桃酸(CHMA)对映体在其中的手性识别行为.详细考察了HP-β-CD浓度、CHMA浓度、乙醇和硫酸铵质量分数、体系温度和pH值等因素对CHMA对映体分配比（D）和分离因子(α)的影响.结果显示,含有手性识别剂HP-β-CD的乙醇∕硫酸铵双水相体系对CHMA对映体具有很强的手性识别能力;体系中HP-β-CD浓度、乙醇质量分数、温度和pH值等因素对对映体的分离度影响较大;在体系温度为40 ℃,pH值为2,乙醇质量分数为30%,硫酸铵质量分数为15%,HP-β-CD的浓度为50 g.L-1,CHMA浓度为0.5 mmol.L-1时,手性识别分离效果最佳,分离因子（α）达到了1.86.     

β-环糊精与阿霉素相互作用荧光光谱

用荧光光谱技术确定了β-环糊精（β-CD）与阿霉素（ADM）之间的超分子包络物ADM-β-CD的形成。 研究了时间、浓度和温度对包络反应的影响,确定了包络物形成的化学计量比,计算了在不同温度下的包络常数和包络反应的热力学参数。 在33 ℃、pH=7.0时,包络常数K=2.98×106 L/mol,且包络常数随温度升高而变小,该包络反应属于焓驱动的自发的放热反应。 由于β-CD对ADM的天然荧光有增强作用,因此,ADM与β-CD形成超分子包络物后,荧光强度增大,荧光光谱是研究ADM与β-CD超分子包络反应的很好的技术。 求得β-CD增敏荧光法定量测定ADM的线性回归方程为:F=5.64×108c+47.26,相关系数r=0.9985,检测下限为6.30×10-8 mol/L。     

咪唑基取代β-环糊精聚合物固相萃取剂制备及分析应用

合成了单-6-脱氧-6-咪唑-β-环糊精聚合物（β-CDIMCP）,建立了以β-CDIMCP为固相萃取剂分离分析碱性桃红T的新方法。 结果表明,与β-环糊精聚合物(β-CDCP)相比,β-CDIMCP具有更好的吸附能力。 室温下、pH=11.0时,β-CDIMCP能快速定量吸附碱性桃红T（吸附率95%）;以3.0 mL无水乙醇在8 min内可脱附碱性桃红T（脱附率90.0%）。 在最佳条件下,β-CDIMCP对碱性桃红T富集倍数为10,检出限为4.9 μg/L,相对标准偏差3.4%(n=3,ρ=3.00 mg/L),线性范围为0.09~6.00 mg/L,相关系数R为0.9972。 通过包合常数测定探讨了β-CDIMCP对碱性桃红T的吸附机理。 采用该方法对实际样品中碱性桃红T含量测定,结果令人满意。     

羟丙基-β-环糊精富集提取射干中异黄酮

利用羟丙基-β-环糊精（HP-β-CD）水溶液对中药射干（Belamcanda chinensis）中功能性成分异黄酮类物质富集提取。 考察了时间、温度等对提取效果的影响,确定了优化的工艺条件;结合紫外光谱、高效液相色谱和液相色谱-质谱联用等检测手段,测定提取源总异黄酮含量及黄酮种类。 在此条件下,对异黄酮类物质的提取总量较纯水浸取提高1倍,鸢尾苷提取量可提高2倍。     

β-环糊精及其衍生物对维生素分子的识别作用

以乙基紫(EV)为光谱探针,采用紫外-可见光谱法测定了两种维生素(V)与β-环糊精(β-CD)、羟丙基-β-环糊精(HP-β-CD)和磺丁醚-β-环糊精(SBE-β-CD)的包合特性.结果表明,多种弱相互作用力协同作用于环糊精的包合过程,主-客体间的尺寸匹配影响了包合物的稳定性.包合能力β-CDHP-β-CDSBE-β-CD.     

阴离子型β-环糊精衍生物的合成

以β-环糊精与对甲苯磺酰氯反应制得6-对甲苯磺酰基-β-环糊精酯(1); 1分别与牛磺酸和L-天冬氨酸反应合成了两个阴离子型β-环糊精衍生物单-6-牛磺酸-β-环糊精(2)和单-6-L-天冬氨酸-β-环糊精(3),总收率分别为56.1%和48.7%,其中化合物2未见文献报道,其结构经¹H NMR, ¹³C NMR和MS（ESI）表征。并对后处理过程进行了优化。     

荧光光谱法研究维生素B_1与β-环糊精及其衍生物的包合作用

采用荧光光谱法研究了β-环糊精(β-CD)、甲基-β-环糊精(M-β-CD)、羟丙基-β-环糊精(HP-β-CD)、磺丁基-β-环糊精(SBE-β-CD)对维生素B_1的包合作用.在固定维生素B_1浓度和改变环糊精及其衍生物浓度的情况下,维生素B_1的荧光发射波长的变化以及荧光强度的增强表明了包合物的形成,用荧光双倒数法计算了环糊精及其衍生物与维生素B_1的包合常数.实验结果表明:在pH=7.4的体系中,β-环糊精对维生素B_1的包合能力最强,且四种环糊精与维生素B_1的包合物的包合比均为1∶1.     

Thermodynamic study of inclusion complexes of zaleplon with natural and modified cyclodextrins

The thermodynamics and stoichiometry of zaleplon (ZAL) complexation with different cyclodextrin derivatives [β-CD, hydroxypropyl-β-cyclodextrin (HP-β-CD), randomly methylated-β-cyclodextrin (RAMEB), sulphobutylether-β-cyclodextrin (SBE-β-CD)] in aqueous solution was studied by spectrofluorimetry and ¹H NMR spectroscopy in order to obtain a more general understanding of the driving forces behind the inclusion phenomena. Job’s plot derived from the NMR spectral data and statistical analysis of spectrofluorimetric titration data confirmed the formation of equimolar complexes in all systems tested, excluding the possibility of higher order complex formation. Furthermore, thermodynamic parameters obtained by both techniques gave similar and negative values of ΔG° for all complexes, indicating spontaneous inclusion of drug into CDs. From a thermodynamic point of view, two types of inclusions were determined. One is enthalpy driven ZAL complexation with β-CD, HP-β-CD and RAMEB, while the other is entropy driven complexation observed in the case of SBE-β-CD. The mechanisms behind each type of inclusion were discussed in detail.     

Study on the Supramolecular System of TAPP and Cyclodextrins by Spectroscopy

The ability of β-cyclodextrin (β-CD), γ-CD, hydroxypropyl-β-CD (HP-β-CD), trimethyl-β-CD (TM-β-CD), sulfurbutylether-β-CD (SBE-β-CD) and carboxymethyl-β-cyclodextrin (CM-β-CD) to break the aggregate of the meso-tetrakis(4-N-trimethylaminobenzyl)porphyrin (TAPP) and to form 2:1 inclusion complexes has been studied by absorption and fluorescence spectroscopy. The formation constants are calculated, respectively, by fluorimetry, from which the inclusion capacity of different CDs is compared and the inclusion mechanism of charged-β-CD (SBE-β-CD and CM-β-CD) is quite different from that of the parent β-CD. At lower pH, the complexation between TM-β-CD and H²TAPP²⁺ (the form of the diprotonated TAPP) hampers the continuous protonation of the pyrrole nitrogen of TAPP and the hydrophobic cavity may prefer to bind an apolar neutral porphyrin molecule. ¹HNMR data support the inclusion conformation of the porphyrin–cyclodextrin supramolecular system, indicating the interaction of the meso-phenyl groups of TAPP with the cavity of CDs. For this host–guest inclusion model, cyclodextrin being regarded as the protein component, which acts as a carrier enveloping the active site of heme prosthetic group within its hydrophobic environment, provides a protective sheath for the porphyrin, creating artificial analogues of heme-containing proteins. However, for TAPP, encapsulated within this saccharide-coated barrier, its photophysical and photochemical properties changed strongly.     

Inclusion of Paracetamol into β-cyclodextrin nanocavities in solution and in the solid state

We report on steady-state UV-visible absorption and emission characteristics of Paracetamol, drug used as antipyretic agent, in water and within cyclodextrins (CDs): β-CD, 2-hydroxypropyl-β-CD (HP-β-CD) and 2,6-dimethyl-β-CD (Me-β-CD). The results reveal that Paracetamol forms a 1:1 inclusion complex with CD. Upon encapsulation, the emission intensity enhances, indicating a confinement effect of the nanocages on the photophysical behavior of the drug. Due to its methyl groups, the Me-β-CD shows the largest effect for the drug. The observed binding constant showing the following trend: Me-β-CD>HP-β-CD>β-CD. The less complexing effectiveness of HP-β-CD is due to the steric effect of the hydroxypropyl-substituents, which can hamper the inclusion of the guest molecules. The solid state inclusion complex was prepared by co-precipitation method and its characterization was investigated by Fourier transform infrared spectroscopy, 1H NMR and X-ray diffractometry. These approaches indicated that Paracetamol was able to form an inclusion complex with CDs, and the inclusion compounds exhibited different spectroscopic features and properties from Paracetamol.     

Study on the complexation of isoquercitrin with β-cyclodextrin and its derivatives by spectroscopy

The inclusion complexes of isoquercitrin (IQ) with cyclodextrins (CDs) including β-cyclodextrin (β-CD), hydroxypropyl-β-cyclodextrin (HP-β-CD) and dimethyl-β-cyclodextrin (DM-β-CD) have been investigated using the methods of steady-state fluorescence, UV-vis absorption and induced circular dichroism. The stoichiometric ratio of the three complexes was found to be 1:1 and the stability constants (K) were estimated from spectrofluorometric titrations, as well as the thermodynamic parameters. Maximum inclusion ability was measured in the case of DM-β-CD due to the increased hydrophobicity of the host cavity, followed by HP-β-CD and β-CD. The effect of pH on the complexation process was also quantitatively assessed. IQ exists in different molecular forms depending on pH and β-CDs were most suitable for inclusion of the neutral form of IQ. The phase-solubility diagrams obtained with β-CD, HP-β-CD and DM-β-CD were all classical A_L type. And DM-β-CD provided the best solubility enhancement, 12.3-fold increase compared to 2.8- and 7.5-fold increase for β-CD and HP-β-CD. The apparent stability constants obtained from the solubility data at 25 °C were comparable with those obtained from the fluorescence assays. Moreover, ¹H NMR was carried out, which revealed that the IQ favorably inserted into the inner cavity from the chromone part instead of the phenyl part, which was in agreement with molecular modeling studies.     

Spectroscopic study and antioxidant properties of the inclusion complexes of rosmarinic acid with natural and derivative cyclodextrins

Measurement of total antioxidant activity/capacity of polyphenols in various solvent media necessitates the use of cyclodextrins to solubilize lipophilic antioxidants of poor aqueous solubility. The inclusion complexes of the slightly water soluble antioxidant, rosmarinic acid (RA), with α-cyclodextrin (α-CD), β-cyclodextrin (β-CD), 2-hydroxypropyl-β-cyclodextrin (HP-β-CD), 2-hydroxyethyl-β-cyclodextrin (HE-β-CD), and methyl-β-cyclodextrin (M-β-CD) were investigated for the first time. The effect of cyclodextrins (CDs) on the spectral features of RA was measured in aqueous medium using UV-vis and steady-state fluorescence techniques by varying the concentrations of CDs. The molar stoichiometry of RA-CD inclusion complexes was verified as 1:1, and the formation constants of the complexes were determined from Benesi-Hildebrand equation using fluorescence spectroscopic data. Among the CDs, maximum inclusion ability was measured in the case of M-β-CD followed by HP-β-CD, HE-β-CD, β-CD and α-CD. Solid inclusion complexes were prepared by freeze drying, and their functional groups were analyzed by IR spectroscopy. Antioxidant capacity of CD-complexed rosmarinic acid was measured to be higher than that of the lone hydroxycinnamic acid by the CUPric Reducing Antioxidant Capacity (CUPRAC) method. The mechanism of the TAC increase was interpreted as the stabilization of the 1-e oxidized o-catechol moiety of RA by enhanced intramolecular H-bonding in a hydrophobic environment provided by CDs, mostly by M-β-CD.     

Inclusion complexes of dihydroartemisinin with cyclodextrin and its derivatives: characterization,solubilization and inclusion mode

The characterization, inclusion complexation behavior and binding ability of the inclusion complexes of dihydroartemisinin with β-cyclodextrin and its derivatives, sulfobutyl ether β-cyclodextrin (SBE-β-CD), mono[6-(2-aminoethylamino)-6-deoxy]-β-cyclodextrin (en-β-CD) and mono{6-[2-(2-aminoethylamino)ethylamino]-6-deoxy}-β-cyclodextrin (dien-β-CD), were studied using phenolphthalein as a spectral probe. Spectral titration was performed in aqueous buffer solution (pH ca. 10.5) at 25 °C to determine the binding constants. The inclusion complexation behaviors were investigated in both solution and solid state by means of NMR, TG, XRD. The results showed that the water solubility and thermal stability of dihydroartemisinin were significantly increased in the inclusion complex with cyclodextrins (CDs). According to ¹H NMR and 2D NMR spectroscopy (ROESY), the A, B rings of dihydroartemisinin can be included into the cavity of CDs. The enhanced binding ability of CDs towards dihydroartemisinin was discussed from the viewpoint of the size/shape-fit concept and multiple recognition mechanism between host and guest.     

Host–guest complexation of a nitroheterocyclic compound with cyclodextrins: a spectrofluorimetric and molecular modeling study

Nitroheterocyclic compounds (NC) were candidate drugs proposed for Chagas disease chemotherapy. In this study, we investigated the complexation of hydroxymethylnitrofurazone (NFOH), a potential antichagasic compound, with α-cyclodextrin (α-CD), β-cyclodextrin (β-CD), Hydroxypropyl-β-cyclodextrin (HP-β-CD), Dimethyl-β-cyclodextrin (DM-β-CD) and γ-cyclodextrin (γ-CD) by fluorescence spectroscopy and molecular modeling studies. Hildebrand–Benesi equation was used to calculate the formation constants of NFOH with cyclodextrins based on the fluorescence differences in the CDs solution. The complexing capacity of NFOH with different CDs was compared through the results of association constant according to the following order: DM-β-CD > β-CD > α-CD > HP-β-CD > γ-CD. Molecular modeling studies give support for the experimental assignments, in favor of the formation of an inclusion complex between cyclodextrins with NFOH. This is an important study to investigate the effects of different kinds of cyclodextrins on the inclusion complex formation with NFOH and to better characterize a potential formulations to be used as therapeutic options for the oral treatment of Chagas disease.     

Thermo-reversible flurbiprofen liquid suppository with HP-β-CD as a solubility enhancer: improvement of rectal bioavailability

The purpose of this work was to develop a thermo-reversible flurbiprofen liquid suppository base composed of poloxamer and sodium alginate for the improvement of rectal bioavailability of flurbiprofen. Cyclodextrin derivatives such as α-, β-, γ-cyclodextrin and hydroxypropyl-β-cyclodextrin (HP-β-CD) were used to enhance the aqueous solubility of flurbiprofen. The effects of HP-β-CD and flurbiprofen on the physicochemical properties of liquid suppository were then investigated. Pharmacokinetic studies were performed after rectal administration of flurbiprofen liquid suppositories with and without HP-β-CD or after intravenous administration of commercial Lipfen^® (flurbiprofen axetil-loaded emulsion) to rats, and their pharmcokinetic parameters were compared. HP-β-CD decreased the gelation temperature and reinforced the gel strength and bioadhesive force of liquid suppository, while flurbiprofen was opposed to HP-β-CD. Thermo-reversible flurbiprofen liquid suppository showed the physicochemical properties suitable for rectal administration. The flurbiprofen liquid suppository with HP-β-CD showed significantly higher plasma levels, AUC and C_max of flurbiprofen than those of the liquid suppository without HP-β-CD, indicating that flurbiprofen could be well absorbed due to the enhanced solubility by formation of inclusion complex. Moreover, the flurbiprofen liquid suppository with HP-β-CD showed an excellent bioavailability in that the AUC of flurbiprofen after its rectal administration was not significantly different from that after intravenous administration of commercial Lipfen^®. It is concluded that HP-β-CD could be a preferable solubility enhancer for the development of liquid suppository containing poorly water-soluble drugs.